Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2020.09.10.290908v1?rss=1 Authors: Wilson, K. A., Mostyn, S. N., Frangos, Z. J., Shimmon, S., Rawling, T., Vandenberg, R. J., O'Mara, M. L. Abstract: The human glycine transporter GlyT2 (SLC6A5) has emerged as a promising drug target for the development of new analgesics to manage chronic pain. N-acyl amino acids inhibit GlyT2 through binding to an allosteric binding site to produce analgesia in vivo with minimal overt side effects. In this paper we use a combination of medicinal chemistry, electrophysiology, and computational modelling to explore the molecular basis of GlyT2 inhibition at the allosteric site. We show how N-acyl amino acid head group stereochemistry, tail length and double bond position promote enhanced inhibition by deep penetration into the binding pocket. This work provides new insights into the interaction of lipids with transport proteins and will aid in future rational design of novel GlyT2 inhibitors. Copy rights belong to original authors. Visit the link for more info